Objective: The member of the tumor necrosis factor family LIGHT (lymphotoxin-like inducible protein that competes with glycoprotein D for herpesvirus entry on T cells; TNFSF14 (tumor necrosis factor super family protein 14) is primarily expressed in lymphocytes, in which it induces the expression of pro-inflammatory cytokines and alterations of lipid homeostasis. Recently, the protein was shown to be upregulated in obesity and to induce cytokine secretion from adipocytes. Research Methods and Procedures: Using an automated complementary DNA (cDNA) screen, LIGHT was identified to inhibit adipose differentiation. As cellular models for adipogenesis mouse 3T3-L1, human SGBS (Simpson-Golabi-Behmel syndrome) and primary human preadipocytes differentiated in vitro were used as well as primary human adipocytes to study adipocyte functions. Analysis of lipid deposition by Oil Red O staining, mRNA expression by quantitative reverse transcriptase-PCR, nuclear factor (NF)-kB activation as well as protein secretion by enzyme linked immunosorbent assay and Luminex technology was performed. Results: LIGHT was found to inhibit lipid accumulation in the three models of preadipocytes in a dose-dependent manner without cytotoxic effects. This inhibition of differentiation was probably because of interference at early steps of adipogenesis, as early exposure during differentiation showed the strongest effect, as assessed by decreased peroxisome proliferator-activated receptor-g (PPARg) and CCAAT/enhancer-binding protein-a (C/EBPa) mRNA expression. In contrast to TNFa, basal and insulinstimulated glucose uptake and lipolysis of terminally differentiated mature adipocytes were not altered in the presence of LIGHT. At a concentration sufficient to inhibit differentiation, secretion of proinflammatory cytokines was not significantly induced and NF-kB activity was only modestly induced compared with TNFa. Conclusion: LIGHT is a novel inhibitor of human adipocyte differentiation without adversely influencing central metabolic pathways in adipocytes.
Introduction
During the past decade, the concept of adipose tissue as endocrine organ, secreting various kinds of metabolites, hormones and proteins, has been developed and substantiated. 1 In addition, adipose tissue itself is a target tissue for a variety of hormones and cytokines, which may control its main functions such as lipolysis and lipid storage. Various disturbances of these processes may finally contribute to the development of insulin resistance and type 2 diabetes. 2 The increase in the prevalence of obesity is a global health problem. 3 Enlargement of body fat mass can be because of adipocyte hypertrophy (cell volume expansion), adipocyte hyperplasia (new formation of adipocytes) or both. 4 Fat cell hyperplasia requires the terminal differentiation of preadipocytes continuously resident in adipose tissue to mature adipocytes upon specific signals. During the past years, several secreted proteins have been shown to affect differentiation of adipocyte precursor cells into mature adipocytes and adipocyte metabolism. These proteins include members of the tumor necrosis factor (TNF) superfamily, such as TNFa and lymphotoxin-a, or members of the interleukin (IL) family, such as IL-6. 5 These findings prompted us to search for other proteins previously not known to regulate adipocyte differentiation or lipid deposition. For this purpose, we used an automated complementary DNA (cDNA) screen to search for novel secreted factors that inhibit adipocyte differentiation, which led to the identification of LIGHT (lymphotoxin-like inducible protein that competes with glycoprotein D for herpesvirus entry on T cells; TNFSF14 (tumor necrosis factor super family protein 14)) as a protein that inhibits adipogenesis of murine and human cell lines as well as of primary human preadipocytes.
Materials and methods
Chemicals, antibodies and proteins LIGHT recombinant protein was from Alexis Biochemical (Gruenberg, Germany); all other proteins were purchased from R&D Systems (Wiesbaden, Germany). Cell culture medium was from Gibco (Karlsruhe, Germany), and fetal calf serum from Biochrom (Berlin, Germany). All other chemicals and reagents were from Sigma (Taufkirchen, Germany) or Roth (Karlsruhe, Germany).
cDNA library screening A functional genomics screen to identify new proteins that interfere with adipogenesis was performed on a highthroughput robotics platform as previously described. 6 
Cell culture
The mouse 3T3-L1 cell line and human SGBS (SimpsonGolabi-Behmel syndrome) preadipocytes were cultured as described elsewhere. 7 Human primary preadipocytes were obtained from adipose tissue of patients undergoing elective abdominal surgery without selection for body mass index, age or gender; patients with diabetes, cancer or serious diseases were excluded. Preadipocytes were isolated and cultured as described elsewhere. 8 Differentiation of SGBS and primary preadipocytes was induced with Dulbecco's modified Eagle's medium/F12 medium containing 10 mg ml -1 transferrin, 66 nM insulin, 200 pM triiodothyronine (T3) and 100 nM cortisol. During the first 4 days of differentiation, medium was supplemented with 500 mM 3-isobutyl-1-methylxanthine and 2 mg ml -1 rosiglitazone. 0 , reverse 5 0 -AATCTCCTAGTCCTG-GCTCG-3 0 ) were designed using the PrimerExpress Software (Applied Biosystems). Results were corrected for the expression of glycerolaldehyde-3-phosphate dehydrogenase as internal control.
Glucose uptake
Glucose uptake in differentiated cells was determined as described elsewhere. 9 In brief, cells were incubated in 
Lipolysis
Differentiated primary human preadipocytes cells on day 14 were incubated with colorless Dulbecco's modified Eagle's medium/F12 medium, 2% bovine serum albumin and the proteins under investigation or 1 mM isoproterenol for 48 h, a similar incubation time as used in the literature for members of the TNFa family. The media were assayed for glycerol as a marker of lipolysis using the ATP-Kit-SL (BioThema, Handen, Sweden). Glycerol content of the media was calculated as previously described using a glycerol standard curve. 6 CellTiter 96 Aqueous One Solution (Promega, Mannheim, Germany) was added to the wells to determine the numbers of viable cells.
Cytokine secretion
Freshly isolated mature adipocytes, preadipocytes or in vitro differentiated adipocytes were incubated with 100 ng ml -1 TNFa or 100 ng ml -1 LIGHT for 48 h. The supernatants were collected and IL-6 (eBioscience, San Diego, CA, USA), adiponectin and leptin (R&D Systems) concentrations were determined with enzyme linked immunosorbent assay according to the manufacturer's instructions. A multiplex assay for all other cytokines was performed using the Bioplex system (Bio-Rad) with kits from Bio-Rad and Linco (St Charles, MO, USA) according to the instructions of the manufacturers. Inter-and intra-assay coefficients of variation were o8/o6% for IL-6, o7/o4% for adiponectin and o5/o4% for leptin; in the multiplex assay, o4/o10% for IFNg, o4/o6% for granulocyte-macrophage colony-stimulating factor and o3/o7% for RANTES (regulated on activation, normal T expressed and secreted).
NF-kB activity assay
Nuclear factor (NF)-kB DNA-binding activity was assessed with the TransAM-Kit (Active Motif, Rixensart, Belgium). Differentiated adipocytes were incubated for 30 min with the respective protein and nuclear extracts were prepared using DigmanC buffer (20 mM Hepes, pH 7.9, 0.42 M NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 25% glycerol, 1 mM dithiothreitol, 1 mM phenylmethyl sulfonylfluoride and protease inhibitor Complete-Mini (Roche, Penzberg, Germany)). Cell lysates standardized for protein content were incubated with immobilized oligonucleotides containing an NF-kB consensus binding site. DNA-binding activity was analyzed with antibodies specific for the NF-kB subunits according to the manufacturer's instruction.
Bioplex phosphoprotein assay
Differentiated adipocytes on day 16 were incubated with the respective proteins for 30 min. Cells were lysed in Bioplex lysis buffer according to the instruction of the manufacturer. Cell lysates were analyzed with the Bioplex phosphoprotein and total protein multiplex assay kits for mitogen-activated protein kinase (MAPK) and inhibitor of k-Ba after standardization for protein content.
Statistical analysis
Data were expressed as mean±s.d. For statistical comparison, Student's two-tailed paired t-test was used. A P-value of o0.05 was considered statistically significant in comparison to the respective control cells.
Results

cDNA library screening identified LIGHT as a protein that inhibits adipogenesis in mouse 3T3-L1 and human SGBS preadipocytes
An automated cDNA expression screen was used to identify novel proteins that inhibit adipocyte differentiation. Among the 20 primary hits, seven proteins were already known to show an inhibitory function, 6 and a new cDNA clone was identified encoding the member of the TNF superfamily LIGHT, so far not described to inhibit preadipocyte differentiation. The inhibitory effect of the recombinant protein on differentiation of 3T3-L1 preadipocytes was clearly confirmed by measuring lipid deposition using Nile Red staining in 3T3-L1 cells differentiated for 5 days in the presence or absence of recombinant protein. A dosedependent inhibition of lipid depositions compared with control differentiated cells was observed by 61 ± 5% (with 0.25 mg ml -1 protein), 98±1% (Po0.05 with 0.8 mg ml -1 protein) and 99±2% (Po0.05 with 3 mg ml -1 protein).
The inhibition of adipogenesis by LIGHT could also be confirmed in the human preadipocyte cell strain SGBS with a reduction in lipid content by 76±3% (Po0.05) with 100 ng ml -1 LIGHT. As positive control, TNFa was used in parallel to LIGHT and was found to strongly suppress preadipocyte differentiation, as already known. 10 The inhibition of SGBS cell differentiation by TNFa was similar to that by LIGHT, with a reduction in the lipid content by 80±5% (Po0.05) at a concentration of 100 ng ml -1 TNFa (Figure 1b) . In all subsequent experiments, we were interested in examining the potential of LIGHT to regulate adipogenesis in human cells. Therefore, metabolic functions such as inhibition of differentiation, glucose transport and lipolysis were investigated in primary human preadipocytes as well as Figure 2a ).
To analyze the time course of the inhibitory effects of LIGHT, protein was added on days 0, 4 or 8 after induction of differentiation, and cells were differentiated until day 12. When added on day 0 or day 4 after starting differentiation, LIGHT decreased adipogenesis significantly by 455% (Po0.05) of differentiated control cells, TNFa by 95 ± 4% and 87±9% (Po0.05), respectively. When added on day 8 after induction of differentiation, LIGHT showed no significant inhibition of differentiation, whereas TNFa still showed a significant reduction by 40±11% (Po0.05; Figure 2b ). Thus, the equimolar effects of TNFa on differentiation were stronger than those of LIGHT, and LIGHT only revealed its inhibitory potential when added at early time points of differentiation. The limitation of direct comparability has to be taken into account, as recombinant proteins may differ in their biological activity. Furthermore, no effects on cell viability could be detected by the treatment with LIGHT and TNFa, respectively, as assessed by microscopically monitoring and measurement of lactate dehydrogenase activity in the medium both 24 h after induction and after differentiation in the presence of cytokines (data not shown). Hence, LIGHT caused a concentration-dependent inhibitory effect on primary human preadipocyte differentiation only at early steps of adipogenesis and weaker than comparable concentrations of TNFa without affecting cell viability or cell number. These inhibitory effects are most LIGHT decreases mRNA expression of PPARg, C/EBPa, HSL and adiponectin during differentiation As LIGHT inhibited adipogenesis only at early stages of differentiation, we analyzed whether mRNA expression of PPARg and C/EBPa, two central transcription factors involved in early adipogenesis, are affected. In addition, we analyzed expression of adiponectin, which is an adipocyte-specific protein, and of HSL, a key enzyme for lipolysis. Both are considered as late markers of differentiating adipocytes. Again, TNFa was used in parallel to LIGHT as it is known to downregulate PPARg and to decrease preadipocyte maturation. Preadipocytes were incubated with LIGHT (100 ng ml Figure 2c ), indicating a complete block of differentiation. In addition, 100 ng ml -1 LIGHT decreased adiponectin expression by 70 ± 23% (Po0.05) and hormone-sensitive lipase expression by 88±11% (Po0.05). Our data show that LIGHT inhibits adipogenesis, yet the block is not that complete as observed for TNFa, as both downregulation of lipid accumulation ( Figure 2b ) and expression of differentiation markers (Figures 3a and b) are less pronounced. Taken together, LIGHT interferes with early steps of adipogenesis and, as a consequence, the late markers of adipose differentiation are also inhibited in a similar manner as observed for TNFa.
LIGHT inhibits adipogenesis
LIGHT does not significantly affect adipokine expression in mature fat cells It was recently shown that LIGHT induces proinflammatory signalling and cytokine expression in primary adipocytes. 11 We studied the effect of LIGHT on adipocyte-specific adipokines such as adiponectin and leptin in the supernatants of cultures of fully differentiated preadipocytes (on day 14) by enzyme linked immunosorbent assay. LIGHT did not alter total adiponectin or leptin secretion after 48 h of induction (Figures 4a and b) . As in primary culture the variations of absolute protein levels are very high, for each of the five analyzed preadipocyte differentiation sets from different patients, the differentiated control sample was set to one. The total adiponectin secretion was approximately 4 pg ml -1 and total leptin secretion around 120 pg ml ) and differentiated (Diff.) human primary preadipocytes cultured in the presence of 100 ng ml -1 TNFa or 100 ng ml -1 LIGHT were performed. PPARg (a) and C/EBPa (b) mRNA was determined after 4 and 12 days of differentiation. Adiponectin and HSL mRNA as late markers of adipose differentiation was determined on day 12 after induction (c). Recombinant protein was added from the first day of differentiation and freshly added every second day. The differentiated controls on days 4 and 12 (and for each biological replica) were defined as 1.0, and results were standardized to glycerolaldehyde-phosphate dehydrogenase (GAPDH). Data represent mean ± s.d. of at least six experiments in duplicate. *Po0.05, **Po0.01 vs differentiated control.
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were next incubated for 48 h with 100 ng ml -1 TNFa or 100 ng ml -1 LIGHT and the supernatants were assayed for IL-6, IFNg, RANTES and granulocyte-macrophage colonystimulating factor secretion. Upon stimulation with 100 ng ml -1 TNFa, we observed secretion levels of approximately 2.5 ng ml granulocyte-macrophage colony-stimulating factor and 100 ng ml -1 RANTES. When cells were exposed to 100 ng/ml -1 LIGHT, there was only a rather weak, not significant, effect on the expression of all analyzed cytokines ( Figure 5 ). Hence, even at a high concentration LIGHT had no significant effect on the secretion of selected proinflammatory proteins from adipocytes.
LIGHT induces moderate proinflammatory signalling in adipocytes As LIGHT is known to activate the NF-kB pathway and the phosphorylation/activation of MAPK family members in different cellular systems, we next asked the question of which of these signalling pathways were activated by LIGHT in adipocytes. In differentiated human preadipocytes, a short incubation of 30 min with 100 ng ml -1 TNFa resulted in a significant phosphorylation of inhibitor of k-Ba, c-Jun N-terminal kinase and p38-MAPK, but not Erk2. None of the MAPK family members were significantly activated by 100 ng ml -1 LIGHT using the bioplex phosphoprotein and total protein multiplex assay system, whereas LIGHT significantly induced phosphorylation of inhibitor of k-Ba (2.6-fold, Po0.05), but much weaker than TNFa (17.5-fold, Po0.05; Figure 6a ). Therefore, we assayed the induction of DNA-binding activity of different NF-kB subunits in differentiated adipocytes on day 14 after 30 min of incubation with 100 ng ml -1 TNF-a or 100 ng ml -1 LIGHT. Both proteins stimulated NF-kB binding to immobilized oligonucleotides containing an NF-kB consensus binding site (Figure 6b ). LIGHT showed a significant induction of phosphorylation of the p65 subunit by 45 ± 13% and of the p50 subunit by 51 ± 16% in comparison to unstimulated controls (each Po0.05), whereas no induction of cRel or p52 was observed. In contrast, incubation with 100 ng ml -1 TNFa caused a more than threefold increase in phosphorylation of both the p65 and p50 subunits (data not shown). Taken together, these results show that LIGHT moderately activates the canonical NF-kB pathway in differentiated human adipocytes, but to a clearly lower extent than TNFa, explaining the moderate effects on proinflammatory gene expression described above.
LIGHT does not influence metabolic functions of differentiated human adipocytes As TNFa is well known to impair insulin action and several metabolic pathways in adipose tissue, 9 we studied the effect Diff. LIGHT Undiff.
Diff. Freshly isolated mature adipocytes were incubated with 100 ng ml -1 TNFa or 100 ng ml -1 LIGHT for 48 h. Cytokine concentrations in the supernatant were determined by enzyme linked immunosorbent assay (ELISA) for IL-6, and by Bioplex multiplex technology for all others. Data represent mean±s.d. of five experiments in duplicates, and for each single experiment the TNFa stimulation was set to 100%.
LIGHT inhibits adipogenesis G Tiller et al glucose uptake after 1 h of incubation, the insulin-stimulated glucose uptake was significantly decreased under these conditions. However, 100 ng ml -1 LIGHT did not significantly alter either basal or insulin-stimulated glucose uptake (Figure 7a ). For the assessment of lipolysis in newly differentiated adipocytes, we measured glycerol release into the culture medium. Isoproterenol was used as a stimulator and a positive control (Figure 7b ). Basal glycerol release into medium by untreated cells was approximately 250 mM per 1.5 Â 10 5 cells after 48 h of incubation. Both incubation with 100 ng ml -1 TNFa and 1 mM isoproterenol significantly increased lipolysis by at least twofold, whereas 100 ng ml -1 LIGHT did not alter glycerol release into the medium. Thus, LIGHT does not change central metabolic functions in human adipocytes.
Discussion
We performed a cDNA expression screen using the 3T3-L1 preadipocyte cell line to identify novel secreted proteins with inhibitory potential on adipocyte differentiation. One of the new identified genes was TWEAK; 6 a further gene that we could identify and further characterize was LIGHT, another member of the TNF superfamily. In this study, we report that LIGHT inhibits the differentiation of primary human preadipocytes in a concentration-and time-dependent manner. In addition, we show that LIGHT, in contrast to TNFa, does not affect central metabolic functions such as glucose uptake and lipolysis, nor does it alter adipokine expression and secretion despite a modest activation of the canonical NF-kB pathway. LIGHT is a well-known cytokine with a variety of effects in vitro and in vivo. It is involved in the pathogenesis of several immunological processes and most notably in T-cell activation. Furthermore, a pathophysiological role of LIGHT was suggested in intestinal bowel disease, different autoimmune diseases and cancer progression. 12 In a very recent work, LIGHT was shown to have a role in the context of obesity and adipose tissue function: serum LIGHT concentrations were associated with body mass index and percent fat mass; LIGHT was also found to be produced within adipose tissue by the non-adipocyte component, probably by activated T cells, monocytes, granulocytes and immature dendritic cells, 13 but was not expressed/secreted by human adipocytes. Its receptor (HVEM) was shown to be expressed in adipose tissue cells. 11 Furthermore, dysregulation of LIGHT in mouse T cells resulted in increased plasma triglycerides and cholesterol levels; 14 yet, the underlying mechanisms resulting in deregulated lipid metabolism remain unclear. Therefore, it was tempting to speculate that LIGHT has a specific function in adipose tissue.
The main finding of our study was that the TNF-receptor family member LIGHT interferes with the differentiation of mouse and human preadipocytes to adipocytes. We could show that its receptor HVEM is expressed in both preadipocytes and adipocytes. Hence, the inhibitory effects may occur at different time points of differentiation. Yet, our results implicate an inhibition at a relative early step of the differentiation process as indicated by the prevention of the increase in PPARg and C/EBPa expression upon stimulation of adipogenesis by specific promoting agents. In fully differentiated human adipocytes, a comparable PPARg downregulation by exposure to LIGHT was observed in a recent study. 10 Furthermore, when applied during differentiation,
LIGHT clearly reduced the expression of adiponectin and HSL. These changes may be secondary to the reduced expression of PPARg, reflecting the differentiation stage of the cells. This is supported by the observation that shortterm exposure to LIGHT had no direct effect on adiponectin or leptin secretion in mature adipocytes. For each independent experiment (n ¼ 6), the unstimulated control was set as 1. (b) Nuclear extracts were assayed for NF-kB binding activity using enzyme linked immunosorbent assay (ELISA) with immobilized oligonucleotides containing an NF-kB consensus binding site (n ¼ 5). For each experiment, the TNFa stimulation was set to 1. *Po0.05 vs differentiated untreated control.
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As LIGHT is a member of the TNF superfamily, we characterized its function in adipose-derived cells in parallel with TNFa, which is well known to modulate preadipocyte and adipocyte function. TNFa was repeatedly shown to inhibit adipogenesis and insulin-stimulated glucose uptake, to promote lipolysis in mature adipocytes and to activate the NF-kB signalling pathway within adipose-derived cells. 9 It has been speculated that TNFa could thereby limit adipose tissue expansion. 15 Finally, TNFa was found to directly impair insulin signalling in adipocytes. 16 Compared with the profound effects exerted by TNFa on adipose tissue, a striking finding of this work was that exposure of in vitro differentiated human preadipocytes to LIGHT impaired neither basal and insulin-stimulated glucose uptake nor lipolysis. However, in mice with deregulated LIGHT expression, lipid metabolism was found to be impaired; 14 however, the observed metabolic neutrality of LIGHT on adipocytes in this study needs to be confirmed by in vivo models of obesity. The data presented support the notion that LIGHT shows its effect on adipocyte function through changes of the transcriptional activity in preadipocytes rather than by directly altering lipogenesis or lipolysis. Thus, we could clearly show that LIGHT is acting on fat cell differentiation in adipose tissue without direct effects on metabolic functions. In addition to this metabolic neutrality, we could also show that the production of proinflammatory cytokines by adipocytes was only modestly affected by LIGHT compared with TNFaFat least at the concentrations used in our experiments. Bassols et al. 11 showed a proinflammatory activity of LIGHT for several chemokines at the mRNA and protein level. Yet, it is important to note that in this work the clearest proinflammatory effect was observed at tenfold higher LIGHT concentrations as used in our study, despite the fact that the concentrations used in our experiments were sufficient to potently inhibit differentiation. Moreover, in our experiments cytokine secretion was clearly stronger induced by TNFa than by LIGHT. The family member TNFa is well known to induce leptin and to inhibit adiponectin expression and secretion. 15, 16 These effects are assumed to be involved in its antiadipogenic and its adverse metabolic function. Again, we could not show substantial adverse effects of LIGHT on the production of these adipokines. Thus, based on our data we conclude that LIGHT concentrations, which are sufficient to inhibit differentiation, contribute only to a minor extent to proinflammatory activation in adipocytes. The in vitro applied LIGHT concentrations are higher than reported serum levels. 11 Yet, it is well established that in vitro higher concentrations are necessary; and at least the EC 50 value for inhibition of differentiation determined in this study is very close to serum concentrations with tenfold difference. Despite the rather modest effect on cytokine production we observed an upregulation of the canonical NF-kB pathway by LIGHT, yet again to a much lower extent than by TNFa. MAPK signalling was not induced at all by LIGHT in contrast to TNFa. LIGHT is known as an activator of the NF-kB pathway in different cellular systems including adipocytes as very recently shown. 11, 12 Compared with these data, we can clearly conclude that LIGHT, as for cytokine production, shows much weaker proinflammatory NF-kB activation than TNFa. Beside the downstream pathways of LIGHT and TNFa analyzed in this study, to our knowledge, it is not known whether LIGHT directly regulates PPARg or C/EBPb expression or activity, which might be one explanation for the observed phenotype and may be an issue of future experiments.
In conclusion, using a high-throughput screening approach we identified the member of the TNF superfamily 
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